Curanex Pharmaceuticals

(NASDAQ) CURX

Current Price$0.35

Market Cap$10.30M

Since IPO (2025)-91%

5 YearN/A

1 YearN/A

1 Month-33%

Curanex Pharmaceuticals Financials at a Glance

Market Cap

$10.30M

Revenue (TTM)

$0.00

Net Income (TTM)

$4.23M

EPS (TTM)

$-0.15

P/E Ratio

-2.43

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$0.35

Volume

400

Open

$0.35

Price

$0.35

Volume

400

Open

$0.35

Previous Close

$0.35

Daily Range

$0.35 - $0.35

52-Week Range

$0.26 - $9.18

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$0.35

Volume

400

Open

$0.35

Previous Close

$0.35

Daily Range

$0.35 - $0.35

52-Week Range

$0.26 - $9.18

CURX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curanex Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

Jun Liu

Website

www.curanexpharma.com

Headquarters

Jericho, NY 11753, US

CURX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-72%

Return on Capital

-37%

Return on Assets

-36%

Earnings Yield

-41.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.30M

Shares Outstanding

28.36M

Volume

400

Avg. Volume

4.37M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$4.24M

EBITDA

$4.24M

Operating Cash Flow

$10.48M

Capital Expenditure

$0.00

Free Cash Flow

$10.48M

Cash & ST Invst.

$4.97M

Total Debt

$346.70K

Curanex Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$15.03K

N/A

Gross Margin

0.00%

N/A

Market Cap

$10.30M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$3.07M

-2140.5%

EBITDA

$3.14M

-4813.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.63M

+3007.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$224.01K

N/A

Short Term Debt

$122.69K

N/A

Return on Assets

-36.49%

N/A

Return on Invested Capital

-37.04%

N/A

Free Cash Flow

$857.40K

-262.8%

Operating Cash Flow

$857.40K

-262.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HOTHHoth Therapeutics, Inc.

HOTHHoth Therapeutics, Inc.$0.74+4.15%

CRISCuris, Inc.

CRISCuris, Inc.$0.62+8.17%

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$4.15+1.97%

CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares$0.26-0.98%

PULMPulmatrix, Inc.

PULMPulmatrix, Inc.$1.36+0.00%

ASBPAspire Biopharma Holdings, Inc.

ASBPAspire Biopharma Holdings, Inc.$0.19-7.00%

LGVNLongeveron Inc.

LGVNLongeveron Inc.$0.87+2.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

CPNGCoupang

CPNGCoupang$17.89-0.14%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

POETPoet Technologies

POETPoet Technologies$9.72+0.06%

Questions About CURX

What is the current price of Curanex Pharmaceuticals?

Curanex Pharmaceuticals is trading at $0.35 per share.

What is the 52-week range for Curanex Pharmaceuticals?

Over the past 52 weeks, Curanex Pharmaceuticals has traded between $0.26 and $9.18.

How much debt does Curanex Pharmaceuticals have?

As of the most recent reporting period, Curanex Pharmaceuticals reported total debt of $346,699.

How much cash does Curanex Pharmaceuticals have on hand?

Curanex Pharmaceuticals reported $4.97M in cash and cash equivalents in its most recent financial results.

What is Curanex Pharmaceuticals’s dividend yield?

Curanex Pharmaceuticals does not currently have a dividend yield.

Curanex Pharmaceuticals

Curanex Pharmaceuticals Financials at a Glance

CURX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Curanex Pharmaceuticals

CURX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Curanex Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CURX

What is the current price of Curanex Pharmaceuticals?

What is the 52-week range for Curanex Pharmaceuticals?

How much debt does Curanex Pharmaceuticals have?

How much cash does Curanex Pharmaceuticals have on hand?

What is Curanex Pharmaceuticals’s dividend yield?

Premium Investing Services